Cat.No.: | EAb-0031 |
Product Name: | SETDB1 Polyclonal Antibody |
Product Overview: | Polyclonal antibody to detect SETDB1 in human and mouse samples. |
Antibody Type: | Polyclonal |
Immunogen: | Fusion protein of human SETDB1 |
Host: | Rabbit |
Isotype: | IgG |
Antibody Target: | SETDB1 |
Purification: | Affinity purified |
Appearance: | Colorless liquid |
Formulation: | 100 µg of antibody in 100 µl PBS containing 0.02% sodium azide, 50% glycerol, pH 7.3 |
Applications: | Western blot, Immunohistochemistry, immunoprecipitation |
Recommended Dilutions/Conditions: |
Western blot: 1:500 – 1:1000, IHC: 1:50 – 1:100, IP: 1:50 – 1:100 Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user. |
Positive Control: | Western Blot: Various cell lysates |
Species Reactivity: | Human, mouse |
Shipping: | Gel Pack |
Storage: | -20°C |
Warning: | For Research Use Only! Not For Use in Humans. |
Accession: | Q15047 |
Alternative Name: | ESET, H3K9HMTase4, KG1T, KIAA0067, KMT1E. |
Scientific Background: | The Ergassociated protein with SET domain (ESET), also known as SET domain, bifurcated 1 (SETDB1) protein, is a member of a family of histone lysine methyltransferases, each of which contains a conserved catalytic SET domain originally identified in Drosophila, Enhancer of zeste, and Trithorax proteins. ESET also contains tudor and methylCpGbinding domains, which may coordinate binding to methylated histones and methylated DNA, respectively. ESET methylates histone H3 Lys9, creating a transcriptionally repressive mark that facilitates gene silencing. However, unlike SUV39H histone H3 Lys9 methyltransferases, which function mainly in heterochromatin regions such as pericentric heterochromatin, ESET functions mainly in euchromatic regions to repress gene promoters. ESET interacts with a variety of proteins, including transcription factors (ERG), histone deacetylases (HDAC1/2), DNA methyltransferases (DNMT3A/B) and transcriptional corepressors (mSin3A/B, MBD1, KAP1, the ATFaassociated modulator mAM). mAM forms a complex with ESET, stimulating its methyltransferase activity, specifically the conversion of dimethyl to trimethyl histone H3 Lys9. MBD1 recruits ESET to the CAF1 complex to facilitate methylation of histone H3 Lys9 during replicationcoupled chromatin assembly in S phase. DNMT3A recruits ESET to silenced promoters in cancer cells. ESET may play a role in the pathogenesis of Huntington's disease, since levels of ESET protein and trimethyl histone H3 Lys9 are both increased in diseased brains. |
Product Types | ||
◆ Bioactive Small Molecules | ||
BSM-0027 | UNC0321 (trifluoroacetate salt) | Inquiry |
◆ Antibodies | ||
EAb-0030 | SETD8 Polyclonal Antibody | Inquiry |
EAb-0031 | SETDB1 Polyclonal Antibody | Inquiry |
EAb-0032 | Setd1a Polyclonal Antibody | Inquiry |
EAb-0033 | Setd1b Polyclonal Antibody | Inquiry |
Related Gene / Proteins | |||
SENP3 | SENP8 | SET | SET1 |
SET2 | SET7 | SET8 | SET9 |
SETBP1 | SETD1A | SETD1B | SETD2 |
SETD3 | SETD5 | SETD6 | SETD7 |
SETD8 | SETD9 | SetDB1 | SETDB2 More > |
SETMAR |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools